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Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416A154and COL10A1; instead these genes are downregulated by hypoxia.
Another hypoxia-inducible factor isoform, HIF-3a, is reportedly able to
bind HIF-1a, HIF-2a, and HIF-1b (ARNT) and may inhibit their tran-
scriptional activity. Unlike HIF-1a and HIF-2a, very little is known about
the expression and function of HIF-3a in the context of chondrocyte
biology, but knockdown studies in osteosarcoma cells have implicated it
in the regulation of hypertrophy-related genes. We therefore examined
the expression of HIF-3a in chondrogenic cells at various levels of dif-
ferentiation, and tested its contribution to the HIF-2a/ARNTL-driven
transactivation of MMP13.
Methods:HIF-3amRNA (HIF3A) was quantiﬁed in human bonemarrow
mesenchymal stem cells (MSCs) and human primary articular chon-
drocytes from healthy and osteoarthritic (OA) tissue in three-dimen-
sional cultures and in human embryonic epiphyses. The normal and OA
chondrocytes and MSCs were expanded in monolayer and then redif-
ferentiated or differentiated, respectively, in pellet cultures using our
serum-free deﬁned chondrogenic medium containing dexamethasone
and TGF-b1 in hypoxic culture conditions (2% oxygen). For analysis of
HIF3A in tissues, total RNA was extracted via laser capture micro-
dissection from different zones of human embryonic growth plates.
HIF3A mRNA was quantiﬁed in cells and tissues by qPCR using Taqman
primers speciﬁc to a region shared by all known splice variants. Dual-
luciferase assays were performed using the human chondrocyte cell
line, C28/I2. Cells were transfected with pRL-TK Renilla luciferase con-
trol vector, -1602/þ20-MMP13-Luc reporter construct, and expression
vectors for HIF-2a, full-length HIF-3a (i.e. HIF-3a9), and ARNTL alone or
in combination. Transfected cells were lysed after 24 hours and ﬁreﬂy
and Renilla luciferase measured using the Dual-Luciferase Reporter
Assay System (Promega). To assess in vivo binding interactions, HEK293
cells were transiently transfected with expression vectors for ARNTL-
V5-His and HIF-3a alone or in combination and lysed after 48 hours.
Cell extracts were immunoprecipitated with anti-His antibody. SDS-
PAGE separated proteins in the immunoprecipitates were Western
blotted with anti-HIF-3a antibody (Abcam).
Results: HIF3A expression was very low in dedifferentiated healthy
human chondrocytes but signiﬁcantly increased during rediffer-
entiation (>1000-fold). By comparison, HIF3A was expressed at sig-
niﬁcantly lower levels in chondrocytes from OA joints, expressing
higher levels of COL10A1 and MMP13 when compared to healthy
counterparts. Consistent with this, HIF3A was extremely low in both
undifferentiated and chondrogenically-induced MSCs expressing very
high levels of hypertrophic genes. The inverse association of HIF3Awith
hypertrophic markers was conﬁrmed in vivo by analysis of different
zones of human embryonic growth plate cartilage: HIF3A expression
was highest in the zone containing precursor chondrocytes and lowest
in the hypertrophic zone. A functional role related to hypertrophic gene
expression was conﬁrmed by reporter gene assays. As previously
reported, co-expression of HIF-2a alone with an MMP13 reporter was
sufﬁcient to activate transcription; and co-transfection with ARNTL
enhanced HIF-2a-mediated transactivation. Co-transfection of HIF-3a
decreased the reporter activity driven by either HIF-2a alone or the
combination of HIF-2a and ARNTL. Neither HIF-3a alone nor the com-
bination of HIF-3a and ARNTL activated the reporter, indicating that the
reduction in activity caused by HIF-3a is not due simply to its weaker
transcriptional activity. Immunoprecipitation of ARNTL co-precipitated
with HIF-3a, suggesting competition for this b-subunit as a potential
mechanism for HIF-3a inhibition of MMP13 expression.
Conclusions: HIF-3a has an inverse association with hypertrophic
markers in chondrogenic cells in vitro and in vivo, and can inhibit HIF-
2a/ARNTL-mediated transactivation of MMP13. The ﬁndings presented
here lend support to the hypothesis that HIF-3a is a regulator of
chondrocyte hypertrophic terminal differentiation and suggest that it
should be examined as a potential target in cartilage pathologies.
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Purpose: Type 2 Diabetes (T2D), a disease that causes blood glucose
levels to rise higher than normal and has an impact on insulinutilization, is an important risk factor for Osteoarthritis (OA), the most
prevalent aging-related joint disease that affects millions of people
worldwide. Although epidemiological studies suggest a strong associ-
ation between these diseases, how T2D contributes to the deterioration
of articular cartilage is still unknown. Autophagy is a central homeo-
static mechanism for cellular quality control. Several studies suggest
that autophagy is impaired both in OA and T2D, however, how diabetic
conditions inﬂuence autophagy in articular cartilage remains unex-
plored. The objective of this study is to understand the role of
autophagy in the articular cartilage function under diabetic conditions.
Methods: Human primary articular chondrocytes (HC) and a chon-
drocytic cell line (TC28a2) were cultivated in DMEM high glucose (25
mM glucose) and treated with Insulin (10, 100, 500 nM) for 2, 6 or 24
hours. LC3II levels were evaluated by Western blotting (WB) and
Inmunoﬂuorescence (IF). To explore the molecular mechanism poten-
tially involved in this effect, the phosphorylation status of Akt and the
ribosomal protein S6 (rpS6) was evaluated by WB. To further investigate
whether autophagy activation protects chondrocytes from diabetic
conditions, autophagy was induced by the mammalian target of Rapa-
mycin complex 1 (mTORC1) selective inhibitor, Rapamycin (10 mM).
Furthermore, human cartilage explants were cultivated in DMEM high
glucose and insulin (100, 500, 1000 nM) for 24 hours. Cartilage explants
were evaluated by Safranin O staining andMMP-13 and IL-1b expression
was quantiﬁed by immunohistochemistry (IHC) and WB, respectively.
Expression of LC3 and p-rpS6 was determined by WB in primary human
chondrocytes from Osteoarthritis (OA) and OA-Diabetic patients.
Results: In the presence of high glucose and insulin, autophagy was
decreased in a concentration-dependent-manner in human chon-
drocytes, as indicated by LC3II expression, the main marker of
autophagy activation (TC28-a2; p < 0.05 at 6 hours post-treatment; HC;
p < 0.01 at 24 hours post-treatment compared to untreated condition).
To investigate the mechanism by which autophagy is reduced by
insulin, Akt and rpS6 phosphorylation was analyzed. We observed a
signiﬁcant increase in p-AKT and p-rpS6 levels, suggesting that the
effect of insulin on autophagy is mediated by AKT/mTOR pathway
(TC28-a2 p < 0.05 at 6 hours; HC; p < 0.01 at 2 hours compared to
untreated condition). Furthermore, pharmacological induction of
autophagy by Rapamycin reversed insulin effects on LC3II and p-rbS6
levels (Tc28a2 and HC: p < 0.05 at 24 hours post-treatment), indicating
that autophagy induction prevents insulin-mediated autophagy
downregulation. To evaluate the impact of insulin-mediated autophagy
regulation in the context of articular cartilage biology, cartilage explants
were treated with insulin (100, 500 and 1000 nM) for 24 hours. His-
tological analysis indicated a dramatic loss of proteoglycans after
insulin treatment. The observed cartilage degradation was associated
with an increase in OA pathology biomarkers, MMP-13 and IL-1b
expression (p < 0.01 compared to untreated condition). Remarkably,
cartilage tissue from OA-diabetic patients, showed decreased LC3 and
increased p-rpS6 expression compared to non-diabetic OA patients,
indicating a defect on basal autophagy mechanisms.
Conclusions: Our ﬁndings indicate that diabetic conditions contribute
to impair autophagy in human chondrocytes and cartilage and this is
associated with increased cartilage degradation. Furthermore, diabetic
conditions decreased autophagy in cultured chondrocytes by an AKT/
mTOR-dependent mechanism. Therefore, pharmacological inter-
ventions that activate autophagy by inhibition of mTOR might protect
against T2D-associated OA in human chondrocytes. Our data also
indicate that chondrocytes from OA-diabetic patients exhibit a deﬁcient
basal autophagy. Taking together, these results suggest that impaired
autophagy might be one of the mechanisms by which T2D diabetes
accelerates cartilage degradation.
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